A51.43
Secondary syphilitic oculopathy
Clinical Classification Guidelines
Inclusion Terms
- Secondary syphilitic chorioretinitis
- Secondary syphilitic iridocyclitis, iritis
- Secondary syphilitic uveitis
Medical Intelligence & Overview
Secondary syphilitic oculopathy is a medical condition characterized by eye inflammation caused by the secondary stage of syphilis, a bacterial infection. This condition can affect various parts of the eye, including the choroid, iris, ciliary body, and uveal tract, leading to symptoms that may impair vision if not diagnosed and managed properly. Recognized under the ICD-10 code A51.43, secondary syphilitic oculopathy encompasses several eye conditions such as chorioretinitis, iridocyclitis, iritis, and uveitis that result from syphilis infection.
Causes & Symptoms
Clinical Causes: Progression of untreated or inadequately treated syphilis infection. Spread of Treponema pallidum bacteria from the systemic circulation to ocular tissues during secondary syphilis. Immune-mediated reactions to syphilis bacteria affecting the eye structures. Reactivation or persistence of infection leading to ocular inflammation.
Key Symptoms: Redness and swelling of the eye (conjunctiva or uvea). Blurred vision or vision loss. Light sensitivity (photophobia). Pain or discomfort in or around the eye. Floaters or spots visible in the field of vision. Tearing and discharge from the eye. Possible pinpoint or irregular pupil shapes. Persistent or recurrent eye inflammation.
Diagnostic & Treatment
Diagnosis Path: Diagnosis involves a combination of clinical evaluation and laboratory tests. Ophthalmologic examination typically reveals signs of inflammation in specific eye structures. Blood tests for syphilis, such as the rapid plasma reagin (RPR) or fluorescent treponemal antibody absorption (FTA-ABS) test, help confirm systemic infection. Additional testing, including cerebrospinal fluid analysis, may be necessary if neurosyphilis is suspected. Imaging studies, like fundus photography or ocular ultrasound, can assess extent of eye involvement. Diagnosis requires correlating systemic serological results with ocular findings.
Treatment Protocols: The primary treatment for secondary syphilitic oculopathy is antibiotic therapy, primarily with penicillin, which is effective in eradicating Treponema pallidum bacteria. The specific regimen depends on the severity and extent of ocular involvement and may include:[ - Intravenous penicillin G for more severe cases or neurosyphilis. - Penicillin G or benzathine penicillin for less severe ocular presentations. Adjunct treatments may involve corticosteroids to control inflammation, but these should be used under medical supervision. Early diagnosis and treatment are essential to prevent permanent damage and preserve vision. Regular follow-up with both infectious disease specialists and ophthalmologists is important to monitor response to therapy and detect potential recurrence.
Clinical Advice & FAQs
Billing Guidance
Is A51.43 a billable ICD-10 code?
Yes, A51.43 is a specific, billable code that can be used to indicate a diagnosis for reimbursement purposes.
Documentation
How do I report A51.43?
Clinical documentation must specify the nature of Secondary syphilitic oculopathy and any associated comorbidities for accurate reporting.
Cite this Clinical Reference